In Situ Targeting Nanoparticles-Hydrogel Hybrid System for Combined Chemo-Immunotherapy of Glioma

Scientists developed an in situ sustained-release hydrogel delivery system for combined chemo-immunotherapy of glioma by combined chemotherapy drug and immunoadjuvant through the resection cavity local delivery.